<DOC>
	<DOCNO>NCT01292629</DOCNO>
	<brief_summary>The purpose multi-center clinical trail determine safety efficacy iSert 251 correction aphakia .</brief_summary>
	<brief_title>Comparison Hoya Surgical Optics ( HSO ) iSert 251 Posterior Chamber Aspheric Aphakic Intraocular Lens Historical / Literature Controls .</brief_title>
	<detailed_description>This study evaluate safety effectiveness Hoya Surgical Optics iSert Model 251 IOL follow primary implantation visual correction aphakia adult cataractous lens remove phacoemulsification . Results prospective , multicenter clinical trial use support PMA supplement iSertÂ® 251 IOL .</detailed_description>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Aphakia</mesh_term>
	<criteria>Have diagnose cataract phacoemulsification extraction posterior chamber IOL implantation indicate Have clear intraocular medium Have potential Best Corrected Visual Acuity 20/40 well Have preoperative Best SpectacleCorrected visual acuity 20/40 bad Have ocular pathology abnormality expect reduce best correct visual acuity operative eye study period Are monocular Have current ocular infection Are take systemic steroid antimetabolite Have previous retinal detachment operative eye expect require retinal laser treatment course study Eligibility criterion complete . Contact Hoya Surgical Optics , Inc. information .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>intraocular lens</keyword>
	<keyword>IOL</keyword>
	<keyword>cataract</keyword>
	<keyword>Hoya</keyword>
	<keyword>surgical</keyword>
	<keyword>optic</keyword>
	<keyword>ocular</keyword>
	<keyword>visual acuity</keyword>
</DOC>